Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: An intervention study

European Journal of Medical Research

Volumn 18, Issue 1, 2013, Pages

  Li, Tianran ^a   Song, Bin ^a   Du, Xiangke ^b   Wei, Zhengmao ^b   Huo, Tianlong ^b  

^a Department of Surgery   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Animal model; Bone sialoprotein; Bone marrow derived mesenchymal stem cells; High metastatic potential cell; Integrins; Osteopontin

Indexed keywords

ALPHA5 INTEGRIN; BONE SIALOPROTEIN; CASPASE 3; OSTEOPONTIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; BONE MARROW CELL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; CULTURE MEDIUM; DIGITAL CALIPER; DOWN REGULATION; ENGRAFTMENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INOCULATION; LIVER CELL CARCINOMA; MALE; MESENCHYMAL STEM CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GENE; TUMOR VOLUME; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL LINE; CYTOLOGY; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; INTERVENTION STUDY; LIVER NEOPLASMS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METASTASIS; NUDE MOUSE; PATHOLOGY; LIVER TUMOR;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CARCINOMA, HEPATOCELLULAR; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; INTERVENTION STUDIES; LIVER NEOPLASMS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOPLASM METASTASIS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84884679919     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-18-34     Document Type: Article

References (13)

1. Multidisciplinary management of hepatocellular carcinoma: where are we today? Marrero JA, Semin Liver Dis 2013 33 3 S10 23457037
2. Bone marrow as a potential source of hepatic oval cells. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP, Science 1999 284 1168 1170 10.1126/science.284.5417.1168 10325227 (Pubitemid 29288406)
3. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
4. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Aquino JB, Bolontrade MF, Garcia MG, Podhajcer OL, Mazzolini G, Gene Ther 2010 17 692 708 10.1038/gt.2010.10 20220785
5. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models. Li GC, Ye QH, Dong QZ, Ren N, Jia HL, Qin LX, Oncol Rep 2013 29 713 719 23232668
6. Review and progress of small hepatocellular carcinoma. Tao ZY, Advances in Clinical Oncology Beijing, China: Peking Union Medical College Press, Sun Y, Zhao P, 2005 641 654
7. Hepatocyte-like cells from human mesenchymal stem cells engrafted in regenerating rat liver tracked with in vivo magnetic resonance imaging. Choi D, Kim JH, Lim M, Song KW, Paik SS, Kim SJ, Cheong HJ, Jeon JS, Park HS, Song YS, Khang H, Won JH, Tissue Eng Part C Meth 2008 14 15 23 10.1089/tec.2007.0329 (Pubitemid 351520456)
8. Sequential exposure to cytokines reflecting embryogenesis: the key for in vitro differentiation of adult bone marrow stem cells into functional hepatocyte-like cells. Snykers S, Vanhaecke T, Papeleu P, Luttun A, Jiang Y, Vander Heyden Y, Verfaillie C, Rogiers V, Toxicol Sci 2006 94 330 341 10.1093/toxsci/kfl058 16840566 (Pubitemid 44817149)
9. Inoculation of murine bone marrow mesenchymal stem cells induces tumor necrosis in mouse with orthotopic hepatocellular carcinoma. Jiang HF, Ren J, J Peking Univ Health Sci 2008 40 435 458
10. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Barzilay R, Melamed E, Offen D, Stem Cells 2009 27 2509 2515 10.1002/stem.172 19591229
11. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ, Qin LX, Canc Sci 2010 101 2546 2553 10.1111/j.1349-7006.2010.01738.x
12. Modern Experimental Methods in Pharmacology Beijing, China: Peking Union Medical College Press, Zhang JT, 1998 927
13. BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma. Galmiche A, Ezzoukhry Z, François C, Louandre C, Sabbagh C, Nguyen-Khac E, Descamps V, Trouillet N, Godin C, Regimbeau JM, Joly JP, Barbare JC, Duverlie G, Mazière JC, Chatelain D, Mol Canc Res 2010 8 1116 1125 10.1158/1541-7786.MCR-10-0029